SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-011142
Filing Date
2016-01-06
Accepted
2016-01-06 16:16:50
Documents
1
Period of Report
2016-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4002
  Complete submission text file 0000899243-16-011142.txt   5477
Mailing Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SERES THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142
Business Address
Hashad Wael (Reporting) CIK: 0001663009 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37465 | Film No.: 161327013